Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges
Clinical trial NCT03432273 · COMPLETED
Trial details
- NCT number
- NCT03432273
- Sponsor
- Fertin Pharma A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2018-03-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.